Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring-Reference-Cited by-同舟云学术

Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring

Published:2009-12-07 Issue:8 Volume:45 Page:1352-1356
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Trifilio S M,Scheetz M H,Pi J,Mehta J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009345.pdf

Reference21 articles.

1. Fay JW, Wingard JR, Antin JH, Collins RH, Pineiro LA, Blazar BR et al. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. Blood 1996; 87: 3514–3519.

2. Nash RA, Pineiro LA, Storb R, Deeg HJ, Fitzsimmons WE, Furlong T et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 1996; 88: 3634–3641.

3. Przepiorka D, Devine S, Fay J, Uberti J, Wingard J . Practical considerations in the use of tacrolimus for allogeneic marrow transplantation. Bone Marrow Transplant 1999; 24: 1053–1056.

4. Wingard JR, Nash RA, Przepiorka D, Klein JL, Weisdorf DJ, Fay JW et al. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation. Biol Blood Marrow Transplant 1998; 4: 157–163.

5. Press RR, Ploeger BA, den Hartigh J, van der Straaten T, van Pelt J, Danhof M et al. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. Ther Drug Monit 2009; 31: 187–197.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of CYP3A5 Gene Polymorphisms on Tacrolimus Blood Concentrations and Adverse Events in Allogeneic Hematopoietic Stem Cell Transplant Patients;Transplantation Proceedings;2024-09

2. Effects of Triazole Antifungal Agents on the Plasma Concentration and Dosage of Cyclosporin in Patients with Aplastic Anaemia;Journal of Clinical Pharmacy and Therapeutics;2024-02-27

3. Antifungal prophylaxis and pre-emptive therapy: When and how?;Molecular Aspects of Medicine;2023-08

4. The use of text mining to obtain a historical overview of research on therapeutic drug monitoring;2023-06-29

5. Recommendations on the use of azole antifungals in hematology-oncology patients;Revista Española de Quimioterapia;2023-04-05